Summary
Updated Aug 31, 2026
John W. Kozarich is Director of LIGAND PHARMACEUTICALS INC (LGND). 13 SEC Form 4 filings on record going back to 2025, most recently on 9 June 2026. Most recent open-market trade: sold $352K of LGND on 15 May 2026. Lifetime open-market sales: $1.36M.
Recent Transactions
20Every recent SEC Form 4 transaction John W. Kozarich has reported, most recent first.
Trading Pattern
InsiderAlpha's records for John W. Kozarich go back to 2025: 13 primary Form 4 filings, an average of 6.5 per year. 42 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies John W. Kozarich files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M of LGND open-market activity in the last 12 months
- Andrew Reardon - $7.34M of LGND open-market activity in the last 12 months
- Jason Haas - $3.74M of LGND open-market activity in the last 12 months
- Jason Aryeh - $2.96M of LGND open-market activity in the last 12 months
- John L. Lamattina - $2.44M of LGND open-market activity in the last 12 months
- Nancy Ryan Gray - $1.35M of LGND open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John W. Kozarich?
John W. Kozarich is a corporate insider, tracked as Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John W. Kozarich submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John W. Kozarich been buying or selling stock?
Recorded transactions: 0 open-market purchases and 43 open-market sales ($1.36M) across all tracked filings.
Where can I see all of John W. Kozarich's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John W. Kozarich and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial